Turbine.ai
Turbine was founded for a simple reason; to understand complex cancers better than existing experimental tools in order to solve unmet oncology needs. Through a multidisciplinary team that unites computer science and molecular biology, and the world’s most intricate simulation of cell behavior, we identify treatment options for the 70% of cancers that are currently […]
Simulatory
Simulatory is a swiss company that develops simulation products to provide advanced surgical training and education. Its first product is VRspine that focused on spinal endoscopy.
Rahko
Rahko was acquired by Odyssey Therapeutics in 2021. Odyssey Therapeutics is a biotech company pioneering next gen immunomodulators and oncology medicine.
Owkin
Owkin is a French-American startup that uses artificial intelligence to find the right treatment for every patient. Our focus is to use AI to discover and develop better treatments for unmet medica…
OncoGenomX
OncoGenomX is a prediction software company known for its revolutionary approach to individualized drug-tumor matching, with the mission to end under- and overtreatment of patients, avoid unnecessary costs, and minimize the risk of failure and liability.
IPDx
The humoral immune system monitors and regulates human health via antibodies. IPDx proprietary technology translates the intricate collection of antibodies into actionable data to develop diagnostics that help detect disease earlier and guide treatment decisions.
eMurmur
eMurmur is a technology partner to the global healthcare community specializing in advanced digital auscultation. Supporting heart, lung, and bowel health screenings, the company seeks to elevate the practice of auscultation in every interaction.
Deepeye
deepeye is a decision support algorithm that enables ophthalmologists to provide individual therapy to patients suffering from popular eye diseases like Age-related Macular Degeneration (AMD) and o…
Clue
Clue is a period and cycle tracking app that calculates and predicts users’ periods and PMS based on users’ data and calculates fertility windows based on global averages, which can be made more accurate by users’ entering ovulation test data. Clue has more than 10 million active users.
